Observational Registry Characterizing the CTAG Device With ACTIVE CONTROL

CompletedOBSERVATIONAL
Enrollment

127

Participants

Timeline

Start Date

October 18, 2017

Primary Completion Date

October 9, 2019

Study Completion Date

October 9, 2019

Conditions
Thoracic Diseases
Interventions
DEVICE

CTAG Device with ACTIVE CONTROL

Intent to treat with the CTAG Device with ACTIVE CONTROL in the treatment of aortic diseases as part of routine clinical practice.

Trial Locations (20)

Unknown

University Hospital Angers, Angers

CHU Strasbourg, Strasbourg

University Hospital Köln, Cologne

University of Heidelberg, Heidelberg

St. Franziskus Hospital GmbH, Münster

University Hospital Regensburg, Regensburg

Hospital Civili Brescia, Brescia

Ospedali dei Colli - Monaldi, Napoli

Azienda Ospedaliers San Camilla Forlanni, Roma

University Hospital Amsterdam, Amsterdam

St Antonius Hospital, Nieuwegein

Erasmus Medical Center, Rotterdam

Hospital Universitario Central de Asturias, Oviedo

Hospital Clínico Santiago de Compostela, Santiago de Compostela

Hospital Universitario Miguel Servet, Zaragoza

Orebro University Hospital, Örebro

Uppsala University, Uppsala

Leeds General Infirmary, Leeds

St George's Vascular Institute, London

St Thomas' London / Guy's Hospital, London

All Listed Sponsors
lead

W.L.Gore & Associates

INDUSTRY

NCT03286400 - Observational Registry Characterizing the CTAG Device With ACTIVE CONTROL | Biotech Hunter | Biotech Hunter